 BOULDER, Colo., July 29, 2021 GLOBE NEWSWIRE -- Brickell Biotech, Inc. Brickell Nasdaq: BBI, a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced today that it will report its financial results for the second quarter, ended June 30, 2021. Brickells management will host a conference call and webcast at 4:30 pm ET on Thursday, August 12th to discuss the financial results and recent corporate highlights. 